Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 98
Filter
1.
Front Immunol ; 14: 1234535, 2023.
Article in English | MEDLINE | ID: mdl-37954590

ABSTRACT

Inflammatory bowel disease (IBD) is a chronic inflammatory disease typically involving the gastrointestinal tract but not limited to it. IBD can be subdivided into Crohn's disease (CD) and ulcerative colitis (UC). Extraintestinal manifestations (EIMs) are observed in up to 47% of patients with IBD, with the most frequent reports of cutaneous manifestations. Among these, pyoderma gangrenosum (PG) and erythema nodosum (EN) are the two most common skin manifestations in IBD, and both are immune-related inflammatory skin diseases. The presence of cutaneous EIMs may either be concordant with intestinal disease activity or have an independent course. Despite some progress in research on EIMs, for instance, ectopic expression of gut-specific mucosal address cell adhesion molecule-1 (MAdCAM-1) and chemokine CCL25 on the vascular endothelium of the portal tract have been demonstrated in IBD-related primary sclerosing cholangitis (PSC), little is understood about the potential pathophysiological associations between IBD and cutaneous EIMs. Whether cutaneous EIMs are inflammatory events with a commonly shared genetic background or environmental risk factors with IBD but independent of IBD or are the result of an extraintestinal extension of intestinal inflammation, remains unclear. The review aims to provide an overview of the two most representative cutaneous manifestations of IBD, describe IBD's epidemiology, clinical characteristics, and histology, and discuss the immunopathophysiology and existing treatment strategies with biologic agents, with a focus on the potential pathophysiological associations between IBD and cutaneous EIMs.


Subject(s)
Colitis, Ulcerative , Crohn Disease , Erythema Nodosum , Inflammatory Bowel Diseases , Pyoderma Gangrenosum , Humans , Inflammatory Bowel Diseases/drug therapy , Crohn Disease/drug therapy , Colitis, Ulcerative/drug therapy , Pyoderma Gangrenosum/therapy , Pyoderma Gangrenosum/complications , Erythema Nodosum/therapy , Erythema Nodosum/complications
2.
Indian J Dermatol Venereol Leprol ; 88(4): 464-477, 2022.
Article in English | MEDLINE | ID: mdl-34672479

ABSTRACT

Leprosy is a chronic disease with clinical presentations according to the immunologic spectrum. Lepromatous form is the most advanced, with the highest transmissibility and risk of causing disabilities. Lucio's phenomenon is a rare manifestation among lepromatous patients with a rapid and severe evolution and high mortality. It is difficult to differentiate from ulcerative/necrotic erythema nodosum leprosum and has no consensus on how it should be treated. This article is a qualitative review of the literature after the introduction of multidrug therapy, aiming to bring consensus related to the clinical, laboratory and histopathological diagnostic criteria of the disease and its management.


Subject(s)
Erythema Nodosum , Leprosy, Lepromatous , Leprosy, Multibacillary , Leprosy , Drug Therapy, Combination , Erythema Nodosum/diagnosis , Erythema Nodosum/therapy , Humans , Leprostatic Agents/therapeutic use , Leprosy/diagnosis , Leprosy/drug therapy , Leprosy, Lepromatous/diagnosis , Leprosy, Lepromatous/drug therapy , Leprosy, Lepromatous/pathology , Leprosy, Multibacillary/drug therapy
3.
Int J Rheum Dis ; 24(11): 1370-1377, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34514701

ABSTRACT

INTRODUCTION: Idiopathic granulomatous mastitis (IGM) is a chronic inflammatory breast disease of unknown etiology, and erythema nodosum (EN) is a rare extramammary manifestation of this entity characterized by reddish, tender nodules of the lower legs. We aimed to investigate whether the association of IGM with EN has a role as a prognostic indicator. There are few case reports, and only 1 original article including 12 IGM patients with EN has been reported. METHODS: We present 43 women with IGM coexisting with EN and 43 with a diagnosis of IGM only, who were randomly selected from 610 patients for a control group. To the best of our knowledge, this paper comprises the first comparative study of the coexistence of IGM and EN to be reported in the literature. RESULTS: Our findings show that the association of IGM with EN indicates a more aggressive disease course. White blood cells, erythrocyte sedimentation rate, and C-reactive protein were significantly higher in the EN-positive group (P < .05). Arthralgia, breast feeding, fistula distribution and recurrence distributions were significantly higher in the EN-positive group (P < .05). CONCLUSION: Since fistula distribution and recurrence rates were higher in EN-positive group, association of IGM with EN may be an indictor of a worse prognosis. The present study highlights the importance of dermatological care. All physicians should not neglect questioning breast complaints in patients with EN since EN may be caused by IGM.


Subject(s)
Erythema Nodosum/complications , Granulomatous Mastitis/complications , Adult , Cutaneous Fistula/etiology , Erythema Nodosum/diagnosis , Erythema Nodosum/therapy , Female , Granulomatous Mastitis/diagnosis , Granulomatous Mastitis/therapy , Humans , Recurrence , Retrospective Studies , Risk Factors , Time Factors , Treatment Outcome
4.
BMJ Case Rep ; 13(9)2020 Sep 09.
Article in English | MEDLINE | ID: mdl-32912879

ABSTRACT

We report a 50-year-old Caucasian woman who presented with recurrent erythema nodosum, leg swelling, malaise, weight loss and abdominal pain associated with an IgM lambda paraprotein. She was treated with six courses of an anti-CD20 monoclonal antibody and bendamustine chemotherapy over 6 months with a good clinical response.


Subject(s)
Abdominal Pain , Bendamustine Hydrochloride/administration & dosage , Erythema Nodosum , Immunoglobulin M/analysis , Lymphocytosis , Rituximab/administration & dosage , Schnitzler Syndrome/diagnosis , Abdominal Pain/diagnosis , Abdominal Pain/etiology , Antineoplastic Agents/administration & dosage , Diagnosis, Differential , Erythema Nodosum/blood , Erythema Nodosum/diagnosis , Erythema Nodosum/physiopathology , Erythema Nodosum/therapy , Female , Humans , Lymphocytosis/diagnosis , Lymphocytosis/etiology , Middle Aged , Paraproteins/analysis , Patient Care Management/methods , Treatment Outcome , Weight Loss
5.
BMJ Case Rep ; 13(7)2020 Jul 08.
Article in English | MEDLINE | ID: mdl-32641310

ABSTRACT

Erythema nodosum (EN) is a common dermatological manifestation with many different aetiologies. Often however, the aetiology remains unidentified. We present here a 42-year-old male patient with an EN that is due to an acute COVID-19 infection. Most of the usual aetiologies were excluded by laboratory testing and imaging studies. This case is, to our knowledge, the first report of this cutaneous manifestation in the context of a COVID-19 infection. The EN was successfully treated with the disappearance of the COVID-19 infection and topical corticosteroids.


Subject(s)
Analgesics/administration & dosage , Coronavirus Infections , Erythema Nodosum , Glucocorticoids/administration & dosage , Pandemics , Pneumonia, Viral , Tomography, X-Ray Computed/methods , Adult , Betacoronavirus/isolation & purification , COVID-19 , COVID-19 Testing , Clinical Laboratory Techniques/methods , Coronavirus Infections/complications , Coronavirus Infections/diagnosis , Coronavirus Infections/physiopathology , Diagnosis, Differential , Erythema Nodosum/diagnosis , Erythema Nodosum/etiology , Erythema Nodosum/therapy , Humans , Male , Pneumonia, Viral/complications , Pneumonia, Viral/diagnosis , Pneumonia, Viral/physiopathology , Radiography, Thoracic/methods , SARS-CoV-2 , Skin Cream/administration & dosage , Treatment Outcome
6.
Mult Scler Relat Disord ; 28: 155-158, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30597324

ABSTRACT

Erythema nodosum is an uncommon cutaneous hypersensitivity reaction characterized by tender round slightly raised red nodules that become bruise-like and then resolve without scarring. It may be caused by infections, pregnancy, malignancy, systemic illnesses, or idiopathic. Several drugs have been reported in association with erythema nodosum including oral contraceptive pills, penicillin, and sulphonamides. Glatiramer acetate is the only medication used in the treatment of multiple sclerosis that has been reported as a possible cause of erythema nodosum. The association between erythema nodosum and multiple sclerosis or dimethyl fumarate has not been reported in the literature. In this article, we aim to report the first case of a possible association between erythema nodosum and dimethyl fumarate in a multiple sclerosis patient. We hypothesize that dimethyl fumarate may be the cause for the development of erythema nodosum in our patient. The underlying mechanism a possibly related to a delayed hypersensitivity reaction.


Subject(s)
Dimethyl Fumarate/adverse effects , Erythema Nodosum/etiology , Immunosuppressive Agents/adverse effects , Multiple Sclerosis/drug therapy , Adult , Diagnosis, Differential , Dimethyl Fumarate/therapeutic use , Erythema Nodosum/diagnosis , Erythema Nodosum/pathology , Erythema Nodosum/therapy , Female , Humans , Immunosuppressive Agents/therapeutic use , Multiple Sclerosis/diagnostic imaging
7.
World J Pediatr ; 14(6): 548-554, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30269303

ABSTRACT

BACKGROUND: Erythema nodosum can be associated with a number of systemic diseases. There is, however, a paucity of information in the pediatric literature on this condition. The purpose of this article is to familiarize pediatricians with the evaluation, diagnosis, and treatment of erythema nodosum. DATA SOURCES: A PubMed search was completed in Clinical Queries using the key terms "erythema nodosum". RESULTS: Clinically, erythema nodosum presents with a sudden onset of painful, erythematous, subcutaneous nodules mainly localized to the pretibial areas. Lesions are usually bilateral and symmetrical, ranging from 1 to 5 cm in diameter. Erythema nodosum may be associated with a variety of conditions such as infection, medications, sarcoidosis, pregnancy, inflammatory bowel disease, vaccination, autoimmune disease, malignancy, and miscellaneous causes. The condition is idiopathic in approximately 50% of cases. The diagnosis is mainly clinical with biopsy reserved for atypical cases. To evaluate for the underlying cause, some basic laboratory screening studies are worthwhile in most cases and include a complete blood cell count, erythrocyte sedimentation rate and/or C-reactive protein, throat swab culture, antistreptococcal O titers, and a chest radiograph. Other tests should be individualized, guided by the history and physical examination results. Most cases of erythema nodosum are self-limited and require no treatment. Bed rest and leg elevation are generally recommended to reduce the discomfort. Nonsteroidal anti-inflammatory drugs are the first-line treatment for pain management. CONCLUSIONS: As erythema nodosum is often a cutaneous manifestation of a systemic disease, a thorough search should be performed to reveal the underlying cause.


Subject(s)
Erythema Nodosum , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Bed Rest , Clinical Laboratory Techniques , Diagnosis, Differential , Erythema Nodosum/diagnosis , Erythema Nodosum/etiology , Erythema Nodosum/therapy , Humans , Pain Management , Prognosis , Stockings, Compression
8.
Prensa méd. argent ; 104(3): 109-113, may2018. fig
Article in Spanish | BINACIS, LILACS | ID: biblio-1052702

ABSTRACT

Leprosy is a contagious, chronic infectious disease caused by Mycobacterium leprae. The immune response of the host to this bacillus is variable, determining different clinical forms of the same disease. Between the Lepromatous and Tuberculoid spectra, both stable clinical forms, the Dimorfo type can be presented, with great immunological instability, determining clinical characteristics, according to the pole to which most approaches. Leproatous dimorphic leprosy is characterized by brwn and violet macules, large number of lesions and less definition at its edges, variable sizes and alteration of sensitivity. Conjugal leprosy occurs in very few cases, knowing that intimate contaqct for a long time is an important factor, but has also demonstrated the fundamental role of immunity and genetics to acquire and develop the disease. We present two cases of lepromatous dimorphic leprosy in spouses, with 20 years of cohabitation, in which the same clinical presentation was found. Ths is an infrequent fact, given the low infectivity of the pathogen and the multiple varieties that could occur.


Subject(s)
Humans , Male , Female , Middle Aged , Leprosy, Borderline/immunology , Leprosy, Lepromatous/immunology , Disease Transmission, Infectious/prevention & control , Erythema Nodosum/diagnosis , Erythema Nodosum/therapy , Leprosy, Multibacillary/therapy
9.
Expert Rev Gastroenterol Hepatol ; 11(3): 203-214, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28095714

ABSTRACT

INTRODUCTION: Skin manifestations are common in patients with inflammatory bowel diseases (IBD) and can be part of a concomitant illness with a shared genetic background, an extra-intestinal manifestation of the disease, or a drug side-effect. Areas covered: We provide a practical overview of the epidemiology, pathogenesis, diagnosis, therapeutic approach and prognosis of the most frequent disease-related and drug-induced cutaneous manifestations in IBD, illustrated by cases encountered in our clinical practice. Among the most frequently encountered IBD-related lesions are erythema nodosum, pyoderma gangrenosum and Sweet's syndrome. Common skin manifestations with a strong association to TNF antagonists are local injection site reactions, psoriasiform lesions, cutaneous infections, vasculitides and lupus-like syndromes. In addition, we discuss the relation of thiopurines and TNF antagonists with the risk of skin cancer. Expert commentary: We hope this review will help caretakers involved in the management of IBD patients to recognize the lesions and to manage them in close collaboration with a dedicated dermatologist.


Subject(s)
Anti-Inflammatory Agents/adverse effects , Drug Eruptions/epidemiology , Erythema Nodosum/epidemiology , Gastrointestinal Agents/adverse effects , Inflammatory Bowel Diseases/drug therapy , Pyoderma Gangrenosum/epidemiology , Skin Neoplasms/epidemiology , Skin/drug effects , Sweet Syndrome/epidemiology , Adult , Drug Eruptions/diagnosis , Drug Eruptions/therapy , Erythema Nodosum/diagnosis , Erythema Nodosum/therapy , Female , Humans , Incidence , Inflammatory Bowel Diseases/diagnosis , Inflammatory Bowel Diseases/epidemiology , Male , Middle Aged , Pyoderma Gangrenosum/diagnosis , Pyoderma Gangrenosum/therapy , Risk Factors , Skin/pathology , Skin Neoplasms/chemically induced , Skin Neoplasms/diagnosis , Skin Neoplasms/therapy , Sweet Syndrome/diagnosis , Sweet Syndrome/therapy , Treatment Outcome
11.
Fontilles, Rev. leprol ; 30(5): 517-536, mayo-ago. 2016. tab, ilus
Article in Spanish | IBECS | ID: ibc-156069

ABSTRACT

La hipótesis de trabajo es que el Mycobacterium leprae (M. leprae) viable desempeña un papel crucial en la precipitación de la reacción tipo 1 (T1R) en lepra. Materiales y métodos: Se estudiaron un total de 165 nuevos pacientes multibacilares. Para demostrar la presencia de M. leprae se emplearon tres técnicas en las lesiones en reacción T1R (+), como son el crecimiento en la almohadilla plantar (MFP), detección inmunohistoquímica de la proteína secretora M. leprae Ag85, y 16s rRNA - empleando RT-PCR in situ. Como controles, se emplearon biopsias de BEC y lesiones sin reacción T1R (-). Hallazgos: Un número significativamente mayor de homogeneizados de biopsia de lesión obtenidos al inicio, de casos T1R (+) han presentado crecimiento en MFP, demostrando la presencia de bacterias viables comparado con T1R (-) (P = 0·005). En contraste, pocas biopsias BEC resultaron positivas tanto en T1R (+) como en T1R (-). Con respecto a Ag85, mientras que la positividad total fue más elevada en T1R (+) (74%), la positividad de la tinción (Grado ≥ 2+) era significativamente mayor en el grupo T1R (+) BT-BB 11/20 (55%). En las muestras de biopsias en casos de T1R recurrentes, tanto el Ag 85 como el 16s rRNA, la positividad (62% y 100%) fue mayor en el grupo T1R (+). Se propone que las bacterias viables son componentes esenciales en las T1R y la diferencia en la calidad de los bacilos y no la cantidad o la ratio de inactivos/viables desempeña un papel en la precipitación de T1R. En conclusión, los hallazgos demuestran que los bacilos «metabólicamente activos» de M. leprae son un componente/requisito fundamental de la T1R y la proteína secretora Ag 85, quizás sea el precipitador de T1R (AU)


The working hypothesis is that, viable Mycobacterium leprae (M. leprae) play a crucial role in the precipitation of Type 1 reaction (T1R) in leprosy. Material and Methods: A total of 165 new multibacillary patients were studied. To demonstrate presence of viable M. leprae in reactional lesion (T1R+), three tests were used concurrently viz. growth in the mouse foot pad (MFP), immunohistochemical detection of M. leprae secretory protein Ag85, and 16s rRNA - using in situ RT- PCR. Mirror biopsies and non reactional lesions served as controls T1R (-). Findings: A significantly higher proportion of lesion biopsy homogenates obtained at onset, from T1R (+) cases have shown unequivocal growth in MFP, proving the presence of viable bacteria, as compared to T1R (-) (P , 0·005). In contrast, few Mirror biopsies were positive in both T1R (+) and T1R (-). With respect to Ag85, while the overall positivity was higher in T1R (+) (74%), however the intensity of staining (Grade ≥ 2+) was disproportionately higher in T1R (+) BT-BB lesions 11/20 (55%). In the rebiopsies obtained during a repeat episode of T1R, Ag 85 as well as 16s rRNA, positivity (62% & 100%) was higher in T1R (+). It is inferred therefore «viable» bacteria are an essential component in T1R and difference in the quality of bacilli, not the quantity or the ratio of dead to viable play a role in the precipitation of T1R. In conclusion, the findings show that «metabolically active» M. leprae is a component/prerequisite and the secretory protein Ag 85, might be the trigger for precipitation of T1R (AU)


Subject(s)
Humans , Male , Female , Adolescent , Young Adult , Adult , Middle Aged , Aged , Mycobacterium leprae/pathogenicity , Erythema Nodosum/therapy , Leprosy/therapy , Adrenal Cortex Hormones/therapeutic use , Immunosuppressive Agents/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Biopsy/methods
13.
Int J STD AIDS ; 27(14): 1354-1355, 2016 12.
Article in English | MEDLINE | ID: mdl-27083192

ABSTRACT

Lymphogranuloma venereum is a sexually transmitted infection caused by Chlamydia trachomatis serovar L1, L2 or L3. Anorectal infections in HIV-positive men who have sex with men comprise the majority of cases in the developed world. We present the case of a 30-year-old HIV-negative man with inguinal type lymphogranuloma venereum accompanied by erythema nodosum.


Subject(s)
Chlamydia trachomatis/isolation & purification , Doxycycline/therapeutic use , Erythema Nodosum/diagnosis , Lymphogranuloma Venereum/drug therapy , Adult , Erythema Nodosum/etiology , Erythema Nodosum/pathology , Erythema Nodosum/therapy , HIV Seronegativity , Humans , Lymphogranuloma Venereum/diagnosis , Male , Treatment Outcome
14.
Head Face Med ; 11: 38, 2015 Dec 28.
Article in English | MEDLINE | ID: mdl-26711936

ABSTRACT

A South African girl with CANDLE Syndrome is reported with emphasis on the orodental features and dental management. Clinical manifestations included short stature, wasting of the soft tissue of the arms and legs, erythematous skin eruptions and a prominent abdomen due to hepatosplenomegaly. Generalized microdontia, confirmed by tooth measurement and osteopenia of her jaws, confirmed by digitalized radiography, were previously undescribed syndromic components. Intellectual impairment posed problems during dental intervention. The carious dental lesions and poor oral hygiene were treated conservatively under local anaesthetic. Prophylactic antibiotics were administered an hour before all procedures.Due to the nature of her general condition, invasive dental procedures were minimal. Regular follow-ups were scheduled at six monthly intervals. During this period, her overall oral health status had improved markedly.The CANDLE syndrome is a rare condition with grave complications including immunosuppression and diabetes mellitus. As with many genetic disorders, the dental manifestations are often overshadowed by other more conspicuous and complex syndromic features. Recognition of both the clinical and oral changes that occur in the CANDLE syndrome facilitates accurate diagnosis and appropriate dental management of this potentially lethal condition.


Subject(s)
Dental Caries/therapy , Erythema Nodosum/complications , Fingers/abnormalities , Child , Cone-Beam Computed Tomography , Dental Caries/etiology , Erythema Nodosum/therapy , Female , Humans
16.
J Spec Oper Med ; 14(4): 122-123, 2014.
Article in English | MEDLINE | ID: mdl-25399380

ABSTRACT

An active duty female Sailor reports to your clinic complaining of tender nodules to her legs beginning 1.5 weeks ago. She is diagnosed with erythema nodosum (EN), a painful disorder of the subcutaneous fat that is usually self-limited but may be a clue to an additional underlying medical diagnosis. This article reviews the pathophysiology, causes, course, diagnosis, and management of EN.


Subject(s)
Erythema Nodosum/diagnosis , Military Personnel , Erythema Nodosum/therapy , Female , Humans , Young Adult
18.
Arch. med. interna (Montevideo) ; 36(2): 79-83, jul. 2014. ilus
Article in Spanish | LILACS | ID: lil-754153

ABSTRACT

El síndrome de Lõfgren, es una variante aguda de la sarcoidosis, que se caracteriza por fiebre, eritema nodoso, adenomegalias hiliares pulmonares y artritis. En general, tiene un curso benigno y autolimitado, que contrasta con las formas crónicas que requieren uso de corticoides y tienen tendencia a la recidiva. Se describe aquí el caso clínico de un paciente joven, de sexo masculino, con artritis pero sin eritema nodoso, lo que dificultó el planteo diagnóstico de síndrome de Lõfgren. Se realiza además una breve descripción comparativa entre la presentación clínica de la sarcoidosis crónica y el síndrome de Lõfgren...


Subject(s)
Humans , Male , Arthritis/diagnosis , Arthritis/therapy , Erythema Nodosum/diagnosis , Erythema Nodosum/therapy , Sarcoidosis/diagnosis , Sarcoidosis/etiology , Sarcoidosis/therapy
20.
Eksp Klin Farmakol ; 76(7): 27-30, 2013.
Article in Russian | MEDLINE | ID: mdl-24006613

ABSTRACT

Fixed erythema--a kind of clinical and histopathologic reaction, fixed drug eruption. The purpose of the study--the study of characteristics of the cytokine profile in patients with erythema and the dynamics of the basal levels of proinflammatory and antiinflammatory cytokines during immunotherapy. All 41 patients with fixed erythema at baseline and after treatment was carried out determination of levels of pro-, anti-inflammatory and regulatory cytokines in the serum by ELISA using test systems "Biosource" (Austria). In patients with fixed erythema Immunovac treatment increased serum IFN-gamma (p < 0.05), IL-1beta (p > 0.05), IL-6. While Kagocel led to an increase in IFN-gamma (p < 0.05), IL-1beta, IL-6 and reduction of TGF-beta (p < 0.05). At the same time in patients with fixed erythema basic therapy contributed to the significant increase in TGF-â and decrease in IL-10. Immunovac-VP-4 had the highest activity for the induction of IFN-gamma. Inclusion in the range of therapeutic and prophylactic measures in patients with fixed erythema immunomodulators promotes activation links innate and adaptive immunity triggers mechanisms, thus increasing the antiviral response in patients with erythema.


Subject(s)
Antigens, Bacterial/therapeutic use , Antiviral Agents/therapeutic use , Erythema Nodosum/blood , Erythema Nodosum/therapy , Immunologic Factors/therapeutic use , Immunotherapy , Adaptive Immunity/drug effects , Adult , Aged , Antigens, Bacterial/pharmacology , Antiviral Agents/pharmacology , Enzyme-Linked Immunosorbent Assay , Erythema Nodosum/immunology , Female , Humans , Immunity, Innate/drug effects , Immunologic Factors/pharmacology , Interferon-gamma/blood , Interferon-gamma/immunology , Interleukin-10/blood , Interleukin-10/immunology , Interleukin-1beta/blood , Interleukin-1beta/immunology , Interleukin-6/blood , Interleukin-6/immunology , Male , Middle Aged , Transforming Growth Factor beta/blood , Transforming Growth Factor beta/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...